Perrigo CO PLC PRGO
We take great care to ensure that the data presented and summarized in this overview for PERRIGO Co plc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PRGO
View all-
Vanguard Group Inc Valley Forge, PA14MShares$383 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13MShares$356 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.1MShares$304 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.14MShares$196 Million0.05% of portfolio
-
State Street Corp Boston, MA6.7MShares$184 Million0.01% of portfolio
-
Deprince Race & Zollo Inc Winter Park, FL4.57MShares$125 Million2.7% of portfolio
-
Neuberger Berman Group LLC New York, NY3.8MShares$104 Million0.09% of portfolio
-
Cooke & Bieler LP3.54MShares$97.1 Million1.11% of portfolio
-
Harry Burn Sound Shore Management Inc3.29MShares$90.1 Million3.3% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E92.83MShares$77.7 Million5.24% of portfolio
Latest Institutional Activity in PRGO
Top Purchases
Top Sells
About PRGO
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Transactions at PRGO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 14
2025
|
Orlando D Ashford Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,943
-21.14%
|
$154,518
$26.01 P/Share
|
May 14
2025
|
Orlando D Ashford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,380
+30.57%
|
$321,880
$26.01 P/Share
|
May 14
2025
|
Albert Manzone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-27.47%
|
$123,604
$26.01 P/Share
|
May 14
2025
|
Albert Manzone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,904
+36.39%
|
$257,504
$26.01 P/Share
|
May 14
2025
|
Adriana Karaboutis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-14.68%
|
$123,604
$26.01 P/Share
|
May 14
2025
|
Adriana Karaboutis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,904
+23.42%
|
$257,504
$26.01 P/Share
|
May 14
2025
|
Jeffrey B Kindler Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-31.05%
|
$123,604
$26.01 P/Share
|
May 14
2025
|
Jeffrey B Kindler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,904
+39.28%
|
$257,504
$26.01 P/Share
|
May 14
2025
|
Geoffrey M. Parker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-14.12%
|
$123,604
$26.01 P/Share
|
May 14
2025
|
Geoffrey M. Parker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,904
+22.73%
|
$257,504
$26.01 P/Share
|
May 14
2025
|
Donal O'Connor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-13.43%
|
$123,604
$26.01 P/Share
|
May 14
2025
|
Donal O'Connor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,904
+21.87%
|
$257,504
$26.01 P/Share
|
May 14
2025
|
Bradley A Alford Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-10.35%
|
$123,604
$26.01 P/Share
|
May 14
2025
|
Bradley A Alford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,904
+17.74%
|
$257,504
$26.01 P/Share
|
May 14
2025
|
Julia M Brown Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,754
-37.18%
|
$123,604
$26.01 P/Share
|
May 14
2025
|
Julia M Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,904
+43.65%
|
$257,504
$26.01 P/Share
|
May 12
2025
|
Geoffrey M. Parker Director |
BUY
Open market or private purchase
|
Direct |
3,500
+12.84%
|
$94,500
$27.1 P/Share
|
Apr 04
2025
|
Robert Willis EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,079
-2.6%
|
$28,054
$26.31 P/Share
|
Apr 04
2025
|
Robert Willis EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,070
+4.75%
|
$53,820
$26.31 P/Share
|
Apr 04
2025
|
Patrick Lockwood Taylor CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,448
-8.75%
|
$167,648
$26.31 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 173K shares |
---|---|
Open market or private purchase | 4.5K shares |
Grant, award, or other acquisition | 85.1K shares |
Payment of exercise price or tax liability | 101K shares |
---|---|
Open market or private sale | 82.3K shares |